These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 15805739)

  • 41. Characterization of the Ebola virus nucleoprotein-RNA complex.
    Noda T; Hagiwara K; Sagara H; Kawaoka Y
    J Gen Virol; 2010 Jun; 91(Pt 6):1478-83. PubMed ID: 20164259
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Ebolavirus VP35 interacts with the cytoplasmic dynein light chain 8.
    Kubota T; Matsuoka M; Chang TH; Bray M; Jones S; Tashiro M; Kato A; Ozato K
    J Virol; 2009 Jul; 83(13):6952-6. PubMed ID: 19403681
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP.
    Noda T; Sagara H; Suzuki E; Takada A; Kida H; Kawaoka Y
    J Virol; 2002 May; 76(10):4855-65. PubMed ID: 11967302
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dynamic Phosphorylation of VP30 Is Essential for Ebola Virus Life Cycle.
    Biedenkopf N; Lier C; Becker S
    J Virol; 2016 May; 90(10):4914-4925. PubMed ID: 26937028
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Insight into the Ebola virus nucleocapsid assembly mechanism: crystal structure of Ebola virus nucleoprotein core domain at 1.8 Å resolution.
    Dong S; Yang P; Li G; Liu B; Wang W; Liu X; Xia B; Yang C; Lou Z; Guo Y; Rao Z
    Protein Cell; 2015 May; 6(5):351-62. PubMed ID: 25910597
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Knockdown of Ebola virus VP24 impairs viral nucleocapsid assembly and prevents virus replication.
    Mateo M; Carbonnelle C; Martinez MJ; Reynard O; Page A; Volchkova VA; Volchkov VE
    J Infect Dis; 2011 Nov; 204 Suppl 3():S892-6. PubMed ID: 21987766
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleoproteins and nucleocapsids of negative-strand RNA viruses.
    Ruigrok RW; Crépin T; Kolakofsky D
    Curr Opin Microbiol; 2011 Aug; 14(4):504-10. PubMed ID: 21824806
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression, purification, crystallization and preliminary X-ray studies of the Ebola VP35 interferon inhibitory domain.
    Leung DW; Ginder ND; Nix JC; Basler CF; Honzatko RB; Amarasinghe GK
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2009 Feb; 65(Pt 2):163-5. PubMed ID: 19194011
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The respiratory syncytial virus nucleoprotein-RNA complex forms a left-handed helical nucleocapsid.
    Bakker SE; Duquerroy S; Galloux M; Loney C; Conner E; Eléouët JF; Rey FA; Bhella D
    J Gen Virol; 2013 Aug; 94(Pt 8):1734-1738. PubMed ID: 23677789
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interactions of Marburg virus nucleocapsid proteins.
    Becker S; Rinne C; Hofsäss U; Klenk HD; Mühlberger E
    Virology; 1998 Sep; 249(2):406-17. PubMed ID: 9791031
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Crystal Structure of the Marburg Virus Nucleoprotein Core Domain Chaperoned by a VP35 Peptide Reveals a Conserved Drug Target for Filovirus.
    Zhu T; Song H; Peng R; Shi Y; Qi J; Gao GF
    J Virol; 2017 Sep; 91(18):. PubMed ID: 28659479
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures.
    Coronel EC; Murti KG; Takimoto T; Portner A
    J Virol; 1999 Aug; 73(8):7035-8. PubMed ID: 10400805
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.
    Di Palma F; Daino GL; Ramaswamy VK; Corona A; Frau A; Fanunza E; Vargiu AV; Tramontano E; Ruggerone P
    Antivir Chem Chemother; 2019; 27():2040206619889220. PubMed ID: 31744306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dynamic phosphorylation of Ebola virus VP30 in NP-induced inclusion bodies.
    Lier C; Becker S; Biedenkopf N
    Virology; 2017 Dec; 512():39-47. PubMed ID: 28915404
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Regulation of Ebola virus VP40 matrix protein by SUMO.
    Baz-Martínez M; El Motiam A; Ruibal P; Condezo GN; de la Cruz-Herrera CF; Lang V; Collado M; San Martín C; Rodríguez MS; Muñoz-Fontela C; Rivas C
    Sci Rep; 2016 Nov; 6():37258. PubMed ID: 27849047
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mapping of the VP40-binding regions of the nucleoprotein of Ebola virus.
    Noda T; Watanabe S; Sagara H; Kawaoka Y
    J Virol; 2007 Apr; 81(7):3554-62. PubMed ID: 17229682
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Location of influenza virus M, NP and NS1 proteins in microinjected cells.
    Davey J; Colman A; Dimmock NJ
    J Gen Virol; 1985 Nov; 66 ( Pt 11)():2319-34. PubMed ID: 2932535
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Assembly and budding of Ebolavirus.
    Noda T; Ebihara H; Muramoto Y; Fujii K; Takada A; Sagara H; Kim JH; Kida H; Feldmann H; Kawaoka Y
    PLoS Pathog; 2006 Sep; 2(9):e99. PubMed ID: 17009868
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Genome structure of Ebola virus subtype Reston: differences among Ebola subtypes. Brief report.
    Ikegami T; Calaor AB; Miranda ME; Niikura M; Saijo M; Kurane I; Yoshikawa Y; Morikawa S
    Arch Virol; 2001 Oct; 146(10):2021-7. PubMed ID: 11722021
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Analysis of Ebola virus and VLP release using an immunocapture assay.
    Kallstrom G; Warfield KL; Swenson DL; Mort S; Panchal RG; Ruthel G; Bavari S; Aman MJ
    J Virol Methods; 2005 Jul; 127(1):1-9. PubMed ID: 15893559
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.